Zenlabs EthicaBOM:530697 +0.93%57 Forward Dividend Yield % is 0.00% as of Jul. 05, 2026. GuruFocus rates BOM:530697 with a GF Score™ of 57/100 and a GF Value™ of ₹29.34 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 66 Medical Distribution companies, Zenlabs Ethica ranks worse than 1515150% on this metric.
As of today (2026-07-05), the Forward Annual Dividend Yield of Zenlabs Ethica is 0.00%.
As of today (2026-07-05), the Trailing Annual Dividend Yield of Zenlabs Ethica is 0.00%.
BOM:530697's Forward Dividend Yield % is not ranked *
in the Medical Distribution industry.
Industry Median: 2.81 * Ranked among companies with meaningful Forward Dividend Yield % only.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Zenlabs Ethica Forward Dividend Yield % Related Terms
BOM:530697 vs MCK, CAH, COR: Forward Dividend Yield % Comparison
For the Medical Distribution subindustry, Zenlabs Ethica's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zenlabs Ethica Forward Dividend Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Zenlabs Ethica's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Zenlabs Ethica's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
Zenlabs Ethica (BOM:530697) has a Forward Dividend Yield % of 0.00% as of Jul. 05, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Zenlabs Ethica and its competitors. According to the industry distribution chart, Zenlabs Ethica ranks #999999 out of 66 companies in the Medical Distribution industry.
Is Zenlabs Ethica's Forward Dividend Yield % too high?
Zenlabs Ethica's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Zenlabs Ethica ranks #999999 out of 66 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Zenlabs Ethica has a GF Score™ of 57/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zenlabs Ethica's Forward Dividend Yield % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Zenlabs Ethica ranks #999999 out of 66 companies for Forward Dividend Yield %. This places Zenlabs Ethica in the lower half of its industry. The industry median Forward Dividend Yield % is 2.81. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Distribution company?
The median Forward Dividend Yield % among Medical Distribution companies is 2.81, based on 66 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Zenlabs Ethica and its competitors. For the Medical Distribution industry, the median Forward Dividend Yield % is 2.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zenlabs Ethica's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenlabs Ethica stock overvalued right now?
Based on GuruFocus' analysis, Zenlabs Ethica (BOM:530697) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹29.34, compared to a current price of ₹35.80 — trading 22% above its estimated fair value. The current Forward Dividend Yield % is 0.00%. Zenlabs Ethica's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Zenlabs Ethica (BOM:530697), the current Forward Dividend Yield % is 0.00% as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zenlabs Ethica (BOM:530697) Overvalued in 2026?
Based on GuruFocus' analysis, Zenlabs Ethica stock appears to be overvalued.
The current stock price of ₹35.80 is trading 22% above its estimated GF Value™ of ₹29.34.
GuruFocus considers Zenlabs Ethica to be Modestly Overvalued.
Key valuation signals for BOM:530697:
Forward Dividend Yield %: 0.00%
GF Value™: ₹29.34 vs. price of ₹35.80 (22% above fair value)
No single metric tells the full story. See the BOM:530697 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zenlabs Ethica Ltd is a pharmaceutical company engaged in the trading of pharmaceutical formulations. It manufactures and markets drugs which include Gastrointestinal disorders, anti-diabetics, anti-hypertensive drugs, anti-infective, soaps, and anti-Bacterial drugs, nutraceuticals, and others. In addition, The company offers more than 600 products across therapeutic segments.
57GF Score
Get the complete analysis for BOM:530697
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530697 has been successfully added to your 